Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mengfei Xiong

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Neuroimage|June 24, 2023
Synaptic density in aging mice measured by [<sup>18</sup>F]SynVesT-1 PETMengfei Xiong, Sahar Roshanbin, Dag Sehlin, et al.
Molecular Imaging and Biology|March 2, 2021
Desorption Electrospray Ionization Mass Spectrometry Imaging of Cimbi-36, a 5-HT<sub>2A</sub> Receptor Agonist, with Direct Comparison to Autoradiography and Positron Emission TomographySophie C Jacobsen, Nikolaj R Speth, Mengfei Xiong, et al.
Analytical Biochemistry|November 25, 2023
Comparing in vitro affinity measurements of antibodies to TfR1: Surface plasmon resonance versus on-cell affinityGillian Bonvicini, Sunitha Bagawath Singh, Patrik Nygren, et al.
JMIR Mhealth and Uhealth|October 30, 2019
Evaluation of Mobile Apps Targeted at Patients With Spondyloarthritis for Disease Monitoring: Systematic App SearchYu Heng Kwan, Wei Jie Ong, Mengfei Xiong, et al.
Pharmaceutics|July 27, 2022
Reduction of αSYN Pathology in a Mouse Model of PD Using a Brain-Penetrating Bispecific AntibodySahar Roshanbin, Ulrika Julku, Mengfei Xiong, et al.
Neuropharmacology|February 12, 2022
In vivo imaging of alpha-synuclein with antibody-based PETSahar Roshanbin, Mengfei Xiong, Greta Hultqvist, et al.
Pharmaceutical Research|May 2, 2022
PET Imaging in Preclinical Anti-Aβ Drug DevelopmentStina Syvänen, Silvio R Meier, Sahar Roshanbin, et al.
Frontiers in Neuroscience|April 20, 2019
The Chemogenetic Receptor Ligand Clozapine N-Oxide Induces <i>in vivo</i> Neuroreceptor Occupancy and Reduces Striatal Glutamate LevelsSimone Bærentzen, Agata Casado-Sainz, Denise Lange, et al.
ACS Chemical Neuroscience|April 12, 2019
Development and Evaluation of Two Potential 5-HT<sub>7</sub> Receptor PET Tracers: [<sup>18</sup>F]ENL09 and [<sup>18</sup>F]ENL10Elina Tampio L'Estrade, Mengfei Xiong, Vladimir Shalgunov, et al.
Journal of Medicinal Chemistry|December 18, 2019
<i>In Vivo Veritas</i>: <sup>18</sup>F-Radiolabeled Glycomimetics Allow Insights into the Pharmacological Fate of Galectin-3 InhibitorsKlas Bratteby, Edvard Torkelsson, Elina Tampio L'Estrade, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Neuroimage|June 24, 2023
Synaptic density in aging mice measured by [<sup>18</sup>F]SynVesT-1 PETMengfei Xiong, Sahar Roshanbin, Dag Sehlin, et al.
Molecular Imaging and Biology|March 2, 2021
Desorption Electrospray Ionization Mass Spectrometry Imaging of Cimbi-36, a 5-HT<sub>2A</sub> Receptor Agonist, with Direct Comparison to Autoradiography and Positron Emission TomographySophie C Jacobsen, Nikolaj R Speth, Mengfei Xiong, et al.
Analytical Biochemistry|November 25, 2023
Comparing in vitro affinity measurements of antibodies to TfR1: Surface plasmon resonance versus on-cell affinityGillian Bonvicini, Sunitha Bagawath Singh, Patrik Nygren, et al.
JMIR Mhealth and Uhealth|October 30, 2019
Evaluation of Mobile Apps Targeted at Patients With Spondyloarthritis for Disease Monitoring: Systematic App SearchYu Heng Kwan, Wei Jie Ong, Mengfei Xiong, et al.
Pharmaceutics|July 27, 2022
Reduction of αSYN Pathology in a Mouse Model of PD Using a Brain-Penetrating Bispecific AntibodySahar Roshanbin, Ulrika Julku, Mengfei Xiong, et al.
Neuropharmacology|February 12, 2022
In vivo imaging of alpha-synuclein with antibody-based PETSahar Roshanbin, Mengfei Xiong, Greta Hultqvist, et al.
Pharmaceutical Research|May 2, 2022
PET Imaging in Preclinical Anti-Aβ Drug DevelopmentStina Syvänen, Silvio R Meier, Sahar Roshanbin, et al.
Frontiers in Neuroscience|April 20, 2019
The Chemogenetic Receptor Ligand Clozapine N-Oxide Induces <i>in vivo</i> Neuroreceptor Occupancy and Reduces Striatal Glutamate LevelsSimone Bærentzen, Agata Casado-Sainz, Denise Lange, et al.
ACS Chemical Neuroscience|April 12, 2019
Development and Evaluation of Two Potential 5-HT<sub>7</sub> Receptor PET Tracers: [<sup>18</sup>F]ENL09 and [<sup>18</sup>F]ENL10Elina Tampio L'Estrade, Mengfei Xiong, Vladimir Shalgunov, et al.
Journal of Medicinal Chemistry|December 18, 2019
<i>In Vivo Veritas</i>: <sup>18</sup>F-Radiolabeled Glycomimetics Allow Insights into the Pharmacological Fate of Galectin-3 InhibitorsKlas Bratteby, Edvard Torkelsson, Elina Tampio L'Estrade, et al.
Pageof 3